Chemours (CC) PT Lowered to $15 at Morgan Stanley
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
Tweet
Share
E-mailGet Alerts CC Hot Sheet
Price: $12.85 --0%
Rating Summary:
7 Buy, 11 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 6 | New: 14
Rating Summary:
7 Buy, 11 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 6 | New: 14
Join SI Premium – FREE
Morgan Stanley analyst Vincent Andrews lowered the price target on Chemours (NYSE: CC) to $15.00 (from $22.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Mizuho Downgrades Chemours (CC) to Neutral
- LVMH (MC:FP) (LVMUY) PT Lowered to EUR530 at Citi
- Tres Tentos Agroindustrial (TTEN3:BZ) PT Lowered to R$18 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
